Cover Image
市場調查報告書

轉染技術的全球市場(試劑法、器具法、病毒法) - 產業分析,市場規模,市場佔有率,成長性,趨勢及預測

Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 300961
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
轉染技術的全球市場(試劑法、器具法、病毒法) - 產業分析,市場規模,市場佔有率,成長性,趨勢及預測 Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年04月24日 內容資訊: 英文 120 Pages
簡介

本報告以轉染技術(將遺傳基因、病毒等核酸導入細胞並增殖的技術)的全球市場為焦點,提供2013-2019年的各技術方式、用途及地區的轉變預測、整體市場趨勢、技術開發、推動與阻礙因素、機會、競爭環境等分析資訊、主要加入企業的簡介,為您概述為以下內容。

第1章 序

  • 報告內容
  • 市場區隔
  • 調查方法
  • 簡稱一覽

第2章 摘要整理

  • 市場一瞥:轉染技術的全球市場
    • 轉染技術的全球市場 - 各方式:2012年(單位:100萬美元)
  • 比較分析:轉染技術的全球市場 - 各地區(金額比)

第3章 市場概要

  • 簡介
  • 市場定義和概要
  • 市場動態
    • 推動要素
      • 蛋白質生產促進轉染技術的利用
      • 大幅度推進轉染的需求擴大的亞洲新興生物醫藥品市場
    • 阻礙因素
      • 高成本成為市場充分擴大的障礙
    • 機會
      • 朝向幹細胞研究的轉染技術
  • 波特的五力分析:轉染技術的全球市場
  • 市場向心力分析
  • 競爭環境

第4章 轉染技術的全球市場 - 各技術方式

  • 概要
    • 轉染技術的全球市場收益 - 各技術方式(單位:100萬美元)
  • 試劑法
    • 試劑法的全球市場收益 - 各試劑類別(單位:100萬美元)
    • 脂質介導轉染(Lipofection)
    • 磷酸鈣
    • 陽離子性聚合物
    • DEAE葡聚糖
    • 活化樹狀聚合物
    • 磁珠
  • 器具法
    • 器具法的全球市場收益 - 各器具類別(單位:100萬美元)
    • 電力穿孔法
    • 微粒子槍技術
    • 顯微注射
    • Laserfection
  • 病毒法
    • 病毒法的全球市場收益(單位:100萬美元)

第5章 轉染技術的全球市場 - 各用途

  • 概要
    • 轉染技術的全球市場收益 - 各用途(單位:100萬美元)
  • 生物醫學研究
    • 生物醫學研究的全球市場收益 - 各研究對象(單位:100萬美元)
    • 基因改造模式
    • 癌症研究
    • 遺傳基因及蛋白質表現研究
    • 藥物研發、藥物開發用細胞為基礎的微陣列
  • 治療藥通知
    • 治療藥通知的全球市場收益 - 各療法(單位:100萬美元)
    • 生物療法
    • 電化學療法
  • 蛋白質生產
    • 蛋白質生產的全球市場收益(單位:100萬美元)

第6章 轉染技術的全球市場 - 各地區

  • 概要
    • 轉染技術的全球市場收益 - 各地區(單位:100萬美元)
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第7章 建議

  • 成功的市場策略
    • 新技術的開發與產品的改善
    • 幹細胞研究轉染的產品系列的強化
  • 障礙與估計未來
    • 高成本成為市場充分擴大的障礙

第8章 企業簡介(企業概要、財務概要、產品系列、產業策略、最新發展)

  • Bio-Rad Laboratories, Inc.
  • Harvard Bioscience, Inc.
  • Life Technologies Corporation
  • Lonza Group Ltd.
  • Merck KGaA
  • Mirus Bio LLC
  • Polyplus-transfection S.A.
  • Promega Corporation
  • QIAGEN
  • Roche Holding AG
  • Sigma-Aldrich Corporation
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.
目錄

Transfection is a technique used to introduce nucleic acids (either DNA or RNA) into cells. This technology helps the cells to regulate gene therapy, mutation of cancer cells and protein metabolism by affecting the nuclear genes. The transfection technology market is driven by factors such as increasing demand for protein production, emerging biopharmaceutical market and rising prevalence of cancer and infectious diseases, globally.

The report explains various advancements taking place in this market and analyses the global transfection technology market by types of methods and applications. The method segment of the market is classified as reagent-based method, instrument-based method and virus-based method.

The reagent-based method is further segmented as lipid mediated transfection (Lipofection), calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers and magnetic beads. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection.The transfection technology market has also been segmented on the basis of its application in biomedical research, therapeutic delivery (biotherapeutics and electro-chemotherapy and electro-immunotherapy) and protein production. Furthermore, the biomedical research segment includes transgenic models, cancer research, gene and protein expression studies and cell-based microarrays for drug discovery and development.

The report includes estimations of the global transfection technology market in terms of its value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current trends and recent developments are taken into consideration while determining the growth rate of the global transfection technology market. The report provides market size and forecasts for each segment, sub-segment and geographic region with CAGR % for the period 2013 - 2019.

Geographically, transfection technology market has been segmented into four regions which include North America, Europe, Asia-Pacific and Rest of the World (RoW). Market sizes, forecasts and % CAGR for each region have been provided. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the transfection technology market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for the existing as well as the new entrants has also been discussed in the study that is expected to help in decision-making.

Some of the major players profiled in the transfection technology market report include companies such as Sigma Aldrich Corporation, SignaGen Laboratories, Lonza Group Ltd., Life Technologies, Bio-Rad Laboratories Inc., Promega Corporation and QIAGEN. Market players are profiled on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The transfection technologymarket is segmented into the following categories:

Transfection Technology Market, by Methods

  • Reagent-based Method
  • Lipid mediated transfection (Lipofection)
  • Calcium phosphate
  • Catonic polymers
  • DEAE-dextran
  • Activated dendrimers
  • Magnetic beads
  • Instrument-based Method
  • Electroporation
  • Biolistic technology
  • Microinjection
  • Laserfection
  • Virus-based Method

Transfection Technology Market, by Applications

  • Bio-medical Research
    • Transgenic models
    • Cancer Research
    • Gene and protein expression studies
    • Cell based microarrays for drug discovery and development
  • Therapeutic Delivery
    • Biotherapeutics
    • Electro-chemotherapy and electro-immunotherapy
  • Protein Production

Transfection Technology Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of The Worl

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Transfection Technology Market (2012 & 2019)
    • 2.1.1 Global Transfection Technology Market, by Methods, 2012 (USD Million)
  • 2.2 Comparative Analysis: Global Transfection Technology Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview

  • 3.1 Market Definition and Overview
  • 3.2 Market Dynamics
    • 3.2.1 Drivers
      • 3.2.1.1 Protein production promotes the use of transfection technology methods
      • 3.2.1.2 Emerging biopharmaceutical markets in Asia boost transfection needs
    • 3.2.2 Restraints
      • 3.2.2.1 High cost prevents sufficient market expansion
    • 3.2.3 Opportunities
      • 3.2.3.1 Transfection technologies for stem cell research
  • 3.3 Porters Five Force Analysis for the Global Transfection Technology Market
    • 3.3.1 Bargaining Power of Suppliers
    • 3.3.2 Bargaining Power of Buyers
    • 3.3.3 Threat of Substitutes
    • 3.3.4 Threat of New Entrants
    • 3.3.5 Competitive Rivalry
  • 3.4 Market Attractiveness Analysis
  • 3.5 Competitive Landscape
    • 3.5.1 Market Share Analysis by Key Players, 2012 (Value %)

Chapter 4 Global Transfection Technology Market, by Methods

  • 4.1 Overview
    • 4.1.1 Global Transfection Technology Market Revenue, by Methods, 2011 - 2019 (USD Million)
  • 4.2 Reagent-based Methods
    • 4.2.1 Global Reagent Based Market Revenue, by Types, 2011 - 2019 (USD Million)
    • 4.2.2 Lipid Mediated Transfection (Lipofection)
      • 4.2.2.1 Global Lipid Mediated Transfection Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.3 Calcium Phosphate
      • 4.2.3.1 Global Calcium Phosphate Transfection Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.4 Cationic Polymers
      • 4.2.4.1 Global Cationic Polymer Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.5 DEAE dextran
      • 4.2.5.1 Global DEAE-dextran Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.6 Activated Dendrimers
      • 4.2.6.1 Global Activated Dendrimers Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.7 Magnetic Beads (Magnet-mediated transfection)
      • 4.2.7.1 Global Magnetic Beads Transfection Market Revenue, 2011 - 2019 (USD Million)
  • 4.3 Instrument-based Methods
    • 4.3.1 Global Instrument Based Method Revenue, by Types, 2011 - 2019 (USD Million)
    • 4.3.2 Electroporation
      • 4.3.2.1 Global Electroporation Market Revenue, 2011 - 2019 (USD Million)
    • 4.3.3 Biolistic Technology
      • 4.3.3.1 Global Biolistic Technology Market Revenue, 2011 - 2019 (USD Million)
    • 4.3.4 Microinjection
      • 4.3.4.1 Global Microinjection Market Revenue, 2011 - 2019 (USD Million)
    • 4.3.5 Laserfection
      • 4.3.5.1 Global Biolistic Technology Market Revenue, 2011 - 2019 (USD Million)
  • 4.4 Virus-based Methods
    • 4.4.1 Global Virus Based Method Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Transfection Technology Market, By Application

  • 5.1 Overview
    • 5.1.1 Global Transfection Technology Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • 5.2 Bio-medical Research
    • 5.2.1 Global Bio-medical Research Market Revenue, by Types, 2011 - 2019 (USD Million)
    • 5.2.2 Transgenic Models
      • 5.2.2.1 Global Transgenic Model Market Revenue, 2011 - 2019 (USD Million)
    • 5.2.3 Cancer Research
      • 5.2.3.1 Global Cancer Research Market Revenue, 2011 - 2019 (USD Million)
    • 5.2.4 Gene and Protein Expression Studies
      • 5.2.4.1 Global Gene and Protein Expression Studies Market Revenue, 2011 - 2019 (USD Million)
    • 5.2.5 Cell Based Microarray for Drug Discovery and Development
      • 5.2.5.1 Global Cell Based Microarray for Drug Discovery and Development Market Revenue, 2011 - 2019 (USD Million)
  • 5.3 Therapeutic Delivery
    • 5.3.1 Global Therapeutics Delivery Market Revenue, by Types, 2011 - 2019 (USD Million)
    • 5.3.2 Biotherapeutics
      • 5.3.2.1 Global Biotherapeutics Market Revenue, 2011 - 2019 (USD Million)
    • 5.3.3 Electro-chemotherapy and Electro-immunotherapy
      • 5.3.3.1 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 - 2019 (USD Million)
  • 5.4 Protein Production
    • 5.4.1 Global Protein Production Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Global Transfection Technology Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Transfection Technology Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2 North America
    • 6.2.1 North America Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • 6.4 Asia-Pacific
    • 6.4.1 Asia-Pacific Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • 6.5 Rest of the World (RoW)
    • 6.5.1 RoW Transfection Technology Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Recommendations

  • 7.1 Market Strategy for Success
    • 7.1.1 Develop new technologies and product improvement
    • 7.1.2 Enhance product portfolio for stem cell research transfection
  • 7.2 Barriers and Future Assumptions
    • 7.2.1 High cost is a barrier for sufficient market expansion

Chapter 8 Company Profiles

  • 8.1 Bio-Rad Laboratories, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Harvard Bioscience, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 Life Technologies Corporation
    • 8.3.1 Company Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 Lonza Group Ltd.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Product Portfolio
    • 8.4.4 Business Strategies
    • 8.4.5 Recent Developments
  • 8.5 Merck KGaA
    • 8.5.1 Company Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Product Portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 Mirus Bio LLC
    • 8.6.1 Company Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Development
  • 8.7 Polyplus-transfection S.A.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Overview
    • 8.7.3 Product Portfolio
    • 8.7.4 Business Strategies
    • 8.7.5 Recent Developments
  • 8.8 Promega Corporation
    • 8.8.1 Company Overview
    • 8.8.2 Financial Overview
    • 8.8.3 Product Portfolio
    • 8.8.4 Business Strategies
    • 8.8.5 Strategic Alliance
    • 8.8.6 Recent Developments
  • 8.9 QIAGEN
    • 8.9.1 Company Overview
    • 8.9.2 Financial Overview
    • 8.9.3 Product Portfolio
    • 8.9.4 Business Strategies
    • 8.9.5 Recent Developments
  • 8.10 Roche Holding AG
    • 8.10.1 Company Overview
    • 8.10.2 Financial Overview
    • 8.10.3 Product Portfolio
    • 8.10.4 Business Strategies
    • 8.10.5 Recent Development
  • 8.11 Sigma-Aldrich Corporation
    • 8.11.1 Company Overview
    • 8.11.2 Financial Overview
    • 8.11.3 Product Portfolio
    • 8.11.4 Business Strategies
    • 8.11.5 Recent Developments
  • 8.12 SignaGen Laboratories
    • 8.12.1 Company Overview
    • 8.12.2 Financial Overview
    • 8.12.3 Product Portfolio
    • 8.12.4 Recent Developments
  • 8.13 Thermo Fisher Scientific, Inc.
    • 8.13.1 Company Overview
    • 8.13.2 Financial Overview
    • 8.13.3 Product Portfolio
    • 8.13.4 Business Strategies
    • 8.13.5 Recent Developments

List of Figures

  • FIG. 1 Transfection Technology: Market Segmentation
  • FIG. 2 Global Transfection Technology Market, by Methods, 2012 (USD Million)
  • FIG. 3 Comparative Analysis: Global Transfection Technology Market, by Geography, 2012 and 2019 (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Transfection Technology Market
  • FIG. 5 Market Attractiveness Analysis: Global Transfection Technology Market, by Geography
  • FIG. 6 Market Share Analysis: Transfection Technology Market, 2012 (Value %)
  • FIG. 7 Global Lipid Mediated Transfection Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 8 Global Calcium Phosphate Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 9 Global Cationic Polymer Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10 Global DEAE-dextran Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11 Global Activated Dendrimers Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12 Global Magnetic Beads Transfection Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13 Global Magnetic Beads Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14 Global Biolistic Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15 Global Microinjection Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16 Global Biolistic Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17 Global Virus Based Method Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18 Global Transgenic Model Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19 Global Cancer Research Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20 Global Gene and Protein Expression Studies Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 21 Global Cell Based Microarray for Drug Discovery and Development Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 22 Global Biotherapeutics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 23 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 24 Global Electro-chemotherapy and Electro-immunotherapy Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 25 North America Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 26 Europe Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 27 Asia-Pacific Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 28 RoW Transfection Technology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 29 Annual Sales: Bio-Rad Laboratories, Inc., Life Science Segment, 2010 - 2012 (USD Million)
  • FIG. 30 Annual Sales: Harvard Bioscience, Inc., 2010 - 2012 (USD Million)
  • FIG. 31 Annual Sales: Life Technologies Corporation, 2010 - 2012 (USD Million)
  • FIG. 32 Annual Sales: Lonza Group Ltd., Bioscience Segment , 2010 - 2012 (USD Million)
  • FIG. 33 Annual Sales: Merck KGaA, Merck Millipore , 2010 - 2012 (USD Million)
  • FIG. 34 Annual Sales: QIAGEN, 2010 - 2012 (USD Million)
  • FIG. 35 Annual Sales: Roche Holding AG, 2010 - 2012 (USD Million)
  • FIG. 36 Annual Sales: Sigma-Aldrich Corporation, 2010 - 2012 (USD Million)
  • FIG. 37 Annual Sales: Thermo Fisher Scientific, 2010- 2012 (USD Million)

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Market Snapshot: Global Transfection Technology Market (2012 & 2019)
  • TABLE 3 Global Transfection Technology Market Revenue, by Methods, 2011 - 2019 (USD Million)
  • TABLE 4 Global Reagent Based Market Revenue, by Types, 2011 - 2019 (USD Million)
  • TABLE 5 Global Instrument Based Market Revenue, by Types, 2011 - 2019 (USD Million)
  • TABLE 6 Global Transfection Technology Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • TABLE 7 Global Bio-medical Research Market Revenue, by Types, 2011 - 2019(USD)
  • TABLE 8 Drug Delivery Methods with their Carriers/Factors
  • TABLE 9 Global Therapeutics Delivery Market Revenue, by Types, 2011 - 2019 (USD Million)
  • TABLE 10 Global Transfection Technology Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top